Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synt...
Leadership
Janet Huffman
CEO, President, CFO, Secretary & Treasurer
James P. Kelly M.A., M.D.
Chief Medical Officer
William Franklin Peacock IV, F.A.C.E.P., FACC, M.D.
